About Synthesis Capital
Synthesis Capital is a Boston-based firm led by a team of investment professionals who previously managed the healthcare venture practice within Advent International for over 14 years. Collectively, the Synthesis Capital Team has led or helped manage over 35 private equity and venture investments in biotechnology, medical device companies and healthcare services at all stages of development, with 28 achieving exit/liquidity events (14 IPOs and 14 Trade Sales). The team has over 100 years of healthcare industry experience in venture capital investing, operations, business development, scientific research and clinical development. Their complementary backgrounds give Synthesis Capital a unique perspective on the key events shaping the healthcare industry and allow us to identify the most promising investment opportunities regardless of stage or geography. They are active partners and provide hands on support to help build successful companies.